News

publication

Jun 23, 2023

ACS Central Science

Click chemistry selectively activates an auristatin protodrug with either intratumoral or systemic tumor-targeting agents

conference

Jun 4, 2023

2023 - ISHAS

A Hyaluronate Derivative Biopolymer Enables Activation of Protodrugs at Tumors in Animals and Humans Using Click Chemistry

media

Jun 1, 2023

SF Business Times

Click chemistry company Shasqi just struck a deal with Johnson & Johnson

press

Jun 1, 2023

Press Release

Shasqi Announces Research Collaboration to Transform Targeted Cancer Treatment

conference

Apr 23, 2023

2023 - AACR - SQP22 Poster

A click chemistry-activated auristatin protodrug (SQP22) demonstrates potency and safety with antibody and intratumoral tumor-targeting agents

conference

Apr 23, 2023

2023 - AACR - SQ3370 Poster

SQ3370, a doxorubicin-based click chemistry therapeutic, promotes a shift from an immunosuppressive towards a T-cell permissive tumor microenvironment in patients

conference

Apr 16, 2023

2023 AACR

CAPAC a modular platform that can improve the safety and efficacy of existing cancer therapies

media

Apr 1, 2023

Drug Discovery World

The Nobel Prize winning power of click chemistry

publication

Mar 29, 2023

Pre print

SQ3370, the first clinical click chemistry-activated cancer therapeutic, shows safety in humans and translatability across species

media

Mar 1, 2023

Life Science Leader

Translating Nobel Prize Winning Science Into Medicine

media

Mar 1, 2023

Pharma's Almanac

What do you view as the most disruptive or transformational technology or development on the horizon?

media

Feb 8, 2023

The Bio Report

A Company That Bets Its Therapies Will Click with Patients